The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Treatment of the overactive bladder: possible central nervous system drug targets.

På svenska

Author

Summary, in English

The well-known side effects of antimuscarinic drugs have focused interest on other modalities of treatment of the overactive bladder. To effectively control bladder activity, identification of suitable targets for pharmacologic intervention is necessary. Such targets may be found in the central nervous system (CNS) or peripherally. Several CNS transmitters may modulate voiding, but few drugs with a defined CNS site of action have been developed for treatment of voiding disorders. Drugs affecting gamma-aminobutyric acid, opioid, serotonin, noradrenaline, dopamine, or glutamatergic receptors and mechanisms are known to influence micturition, and potentially such drugs could be developed for clinical use. However, a selective action on the lower urinary tract may be difficult to obtain.

Publishing year

2002

Language

English

Pages

18-24

Publication/Series

Urology

Volume

59

Issue

5 Suppl 1

Document type

Journal article

Publisher

Elsevier

Topic

  • Urology and Nephrology

Keywords

  • Bladder Diseases : physiopathology
  • Bladder Diseases : drug therapy
  • Dopamine : physiology
  • Human
  • Muscarinic Antagonists : therapeutic use
  • Norepinephrine : physiology
  • Support
  • Serotonin : physiology
  • Non-U.S. Gov't
  • gamma-Aminobutyric Acid : physiology

Status

Published

ISBN/ISSN/Other

  • ISSN: 1527-9995